GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Praxsyn Corp (GREY:PXYN) » Definitions » FCF Margin %

Praxsyn (Praxsyn) FCF Margin % : -28.86% (As of Sep. 2015)


View and export this data going back to 2007. Start your Free Trial

What is Praxsyn FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Praxsyn's Free Cash Flow for the three months ended in Sep. 2015 was $-5.90 Mil. Praxsyn's Revenue for the three months ended in Sep. 2015 was $20.43 Mil. Therefore, Praxsyn's FCF Margin % for the quarter that ended in Sep. 2015 was -28.86%.

As of today, Praxsyn's current FCF Yield % is 0.00%.

The historical rank and industry rank for Praxsyn's FCF Margin % or its related term are showing as below:

PXYN' s FCF Margin % Range Over the Past 10 Years
Min: -17.48   Med: 0   Max: 0
Current: -17.48


PXYN's FCF Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: -0.68 vs PXYN: -17.48


Praxsyn FCF Margin % Historical Data

The historical data trend for Praxsyn's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Praxsyn FCF Margin % Chart

Praxsyn Annual Data
Trend Oct05 Oct06 Oct07 Oct08 Oct09 Dec10 Dec11 Dec12 Dec13 Dec14
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -161.72 -128.09 - -24.84 -35.71

Praxsyn Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -30.16 -53.00 -16.01 17.16 -28.86

Competitive Comparison of Praxsyn's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Praxsyn's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Praxsyn's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Praxsyn's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Praxsyn's FCF Margin % falls into.



Praxsyn FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Praxsyn's FCF Margin for the fiscal year that ended in Dec. 2014 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2014 )/Revenue (A: Dec. 2014 )
=-23.785/66.599
=-35.71 %

Praxsyn's FCF Margin for the quarter that ended in Sep. 2015 is calculated as

FCF Margin=Free Cash Flow (Q: Sep. 2015 )/Revenue (Q: Sep. 2015 )
=-5.895/20.429
=-28.86 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Praxsyn FCF Margin % Related Terms

Thank you for viewing the detailed overview of Praxsyn's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Praxsyn (Praxsyn) Business Description

Traded in Other Exchanges
N/A
Address
61 Spectrum Boulevard, Suite A, Las Vegas, NV, USA, 89101
Praxsyn Corp is a healthcare company, dedicated to providing medical practitioners with medications and services for their patients. Through its retail pharmacy facility, it formulates healthcare practitioner-prescribed medications to serve patients who experience chronic pain. It primarily focuses on non-narcotic and non-habit forming medications using therapeutic and preventative agents for pain management. In addition, the group prepares innovative products that address erectile dysfunction and metabolic issues and other ancillary products. The products of the firm are either picked up directly from pharmacy facility or shipped directly to patients. The business activities are functioned through the regions of United States.